Trial Profile
A Phase III Clinical Trial to Evaluate the Efficacy and Safety of Chondron (Autologus Chondrocyte) in Patients With Cartilage Defects in Their Ankle for 18 Months
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 03 Aug 2017
Price :
$35
*
At a glance
- Drugs Autologous chondrocyte implantation (Primary)
- Indications Cartilage disorders
- Focus Therapeutic Use
- Sponsors Sewon Cellontech Company Limited
- 04 Sep 2015 New trial record